These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 34997211)

  • 21. Alternative tobacco product use and smoking cessation: a national study.
    Popova L; Ling PM
    Am J Public Health; 2013 May; 103(5):923-30. PubMed ID: 23488521
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Extreme solutions for those who do not succeed to quit smoking. About smokeless tobacco and harm reduction].
    Trofor A; Eşanu V; Frăsilă EI
    Pneumologia; 2008; 57(2):105-8. PubMed ID: 18822878
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Smokers' Exposure to Perceived Modified Risk Claims for E-Cigarettes, Snus, and Smokeless Tobacco in the United States.
    Wackowski OA; O'Connor RJ; Pearson JL
    Nicotine Tob Res; 2021 Feb; 23(3):605-608. PubMed ID: 32812028
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Electronic cigarettes: harm reduction or harm prolongation?].
    Hanewinkel R
    Pneumologie; 2023 Apr; 77(4):233-238. PubMed ID: 36977471
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Randomized Trial to Compare Smoking Cessation Rates of Snus, With and Without Smokeless Tobacco Health-Related Information, and a Nicotine Lozenge.
    Nelson PR; Chen P; Battista DR; Pillitteri JL; Shiffman S
    Nicotine Tob Res; 2019 Jan; 21(1):88-94. PubMed ID: 29373698
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Attitudes towards a hypothetical 'clean nicotine' product and harm reduction among smokers.
    Morphett K; Puljević C; Borland R; Carter A; Hall W; Gartner C
    Int J Drug Policy; 2021 Feb; 88():103020. PubMed ID: 33161296
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Nicotine replacement treatment, e-cigarettes and an online behavioural intervention to reduce relapse in recent ex-smokers: a multinational four-arm RCT.
    McRobbie HJ; Phillips-Waller A; El Zerbi C; McNeill A; Hajek P; Pesola F; Balmford J; Ferguson SG; Li L; Lewis S; Courtney RJ; Gartner C; Bauld L; Borland R
    Health Technol Assess; 2020 Dec; 24(68):1-82. PubMed ID: 33270009
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The Role of Nicotine Dependence in E-Cigarettes' Potential for Smoking Reduction.
    Selya AS; Dierker L; Rose JS; Hedeker D; Mermelstein RJ
    Nicotine Tob Res; 2018 Sep; 20(10):1272-1277. PubMed ID: 29065204
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cigarette users' interest in using or switching to electronic nicotine delivery systems for smokeless tobacco for harm reduction, cessation, or novelty: a cross-sectional survey of US adults.
    Berg CJ; Haardoerfer R; Escoffery C; Zheng P; Kegler M
    Nicotine Tob Res; 2015 Feb; 17(2):245-55. PubMed ID: 24951496
    [TBL] [Abstract][Full Text] [Related]  

  • 30. New Product Marketing Blurs the Line Between Nicotine Replacement Therapy and Smokeless Tobacco Products.
    Kostygina G; England L; Ling P
    Am J Public Health; 2016 Jul; 106(7):1219-22. PubMed ID: 27077338
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Emerging nicotine delivery products. Implications for public health.
    Benowitz NL
    Ann Am Thorac Soc; 2014 Feb; 11(2):231-5. PubMed ID: 24575992
    [TBL] [Abstract][Full Text] [Related]  

  • 32. E-Cigarette as a Harm Reduction Approach among Tobacco Smoking Khat Chewers: A Promising Bullet of Multiple Gains.
    Kassim S; Farsalinos KE
    Int J Environ Res Public Health; 2016 Feb; 13(2):240. PubMed ID: 26907315
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Quantifying the effects of promoting smokeless tobacco as a harm reduction strategy in the USA.
    Mejia AB; Ling PM; Glantz SA
    Tob Control; 2010 Aug; 19(4):297-305. PubMed ID: 20581427
    [TBL] [Abstract][Full Text] [Related]  

  • 34. E-cigarettes versus nicotine replacement treatment as harm reduction interventions for smokers who find quitting difficult: randomized controlled trial.
    Myers Smith K; Phillips-Waller A; Pesola F; McRobbie H; Przulj D; Orzol M; Hajek P
    Addiction; 2022 Jan; 117(1):224-233. PubMed ID: 34187081
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Electronic cigarettes for adults with tobacco dependence enrolled in a tobacco treatment program: A pilot study.
    Baldassarri SR; Bernstein SL; Chupp GL; Slade MD; Fucito LM; Toll BA
    Addict Behav; 2018 May; 80():1-5. PubMed ID: 29304395
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The complexity of 'harm reduction' with smokeless tobacco as an approach to tobacco control in low-income and middle-income countries.
    Ayo-Yusuf OA; Burns DM
    Tob Control; 2012 Mar; 21(2):245-51. PubMed ID: 22345261
    [TBL] [Abstract][Full Text] [Related]  

  • 37. E-cigarettes compared with nicotine replacement therapy within the UK Stop Smoking Services: the TEC RCT.
    Hajek P; Phillips-Waller A; Przulj D; Pesola F; Smith KM; Bisal N; Li J; Parrott S; Sasieni P; Dawkins L; Ross L; Goniewicz M; Wu Q; McRobbie HJ
    Health Technol Assess; 2019 Aug; 23(43):1-82. PubMed ID: 31434605
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Diversification of smoking cessation programmes-the role of e-cigarettes].
    Stöver H
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2021 Nov; 64(11):1473-1479. PubMed ID: 34642773
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Interviews with smokers about smokeless tobacco products, risk messages and news articles.
    Wackowski OA; Lewis MJ; Delnevo CD
    Tob Control; 2016 Nov; 25(6):671-678. PubMed ID: 26576840
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Non-cigarette tobacco products: what have we learnt and where are we headed?
    O'Connor RJ
    Tob Control; 2012 Mar; 21(2):181-90. PubMed ID: 22345243
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.